Introduction to Evidence In The Hcc Adjuvant Setting
Let's dive into the details surrounding Evidence In The Hcc Adjuvant Setting. Anthony El-Khoueiry, MD, reviews the
Evidence In The Hcc Adjuvant Setting Comprehensive Overview
Evidence Darren S. Sigal, MD, and Catherine T. Frenette, MD, comment on the criteria for liver resection and the outcomes for patients with ... Ghassan K. Abou-Alfa, MD; Masatoshi Kudo, MD, PhD; Richard S. Finn, MD; and Arndt Vogel, MD, explain the treatment criteria, ...
Dina Ioffe, MD, Fox Chase Cancer Center, discusses using immunotherapy in the neoadjuvant,
Summary & Highlights for Evidence In The Hcc Adjuvant Setting
- Chair, Richard S. Finn, MD, discusses
- Ghassan Abou-Alfa, MD, MBA, Aiwu Ruth He, MD, PhD, Professor Tim Meyer, and Amit Singal, MD, MS, discuss
- Richard S. Finn, MD, and Anthony El-Khoueiry, MD, discuss changes to the treatment algorithm for advanced
- Stephen Lam Chan, MD, FRCP, Chinese University of Hong Kong, Hong Kong, China, discusses the findings of recent studies in ...
- Topic:
That wraps up our extensive overview of Evidence In The Hcc Adjuvant Setting.